ERBB2 and breast cancer: Prognostic risk stratification of breast cancer patients from H&E-stained tissue sample images. This is particularly relevant for the intermediate-risk ER+/HER2− patients, since improved prognosis can provide guidance relating to treatment decisions for adjuvant chemotherapy, and thus reduce over- and undertreatment of patients.